Clinical Trials Directory

Trials / Completed

CompletedNCT01311427

Simplified Tai Chi for Reducing Fibromyalgia Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Oregon Research Institute · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Data from two recent Tai chi studies have found that Tai Chi yields symptomatic benefit in patients with fibromyalgia (FM). The purpose of this study is to confirm those findings in a larger randomized, controlled clinical trial in a community-based setting. We also sought to extend this line of inquiry by closely examining Tai chi's effect on physical function, specifically postural stability. Towards these ends, we conducted a single-blind, randomized controlled clinical trial of an FM modified 8-form Yang-style Tai chi program compared to standard education. Subjects in both conditions meet in small groups two times weekly for 60 minutes over 12 weeks.

Detailed description

120 males and females with fibromyalgia were randomized to participate in a modified 8 form Yang-Style Tai Chi program or a standard group education program. Both programs met in a small group format for twice weekly 60 minute sessions lasting for 12 weeks. 99 subjects completed the protocol. Primary outcomes from the Fibromyalgia Impact Questionnaire were assessed at baseline and 12 weeks. Secondary measures included pain intensity and interference, sleep, coping, and fitness tests.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL8-form Yang-style Tai chiThis study tested a modified 8-form Yang-style Tai chi program in subjects with fibromyalgia. Participants met in a small group two times weekly for 60 minutes over 12 weeks.
BEHAVIORALGroup educationStandard group education was delivered to participants in a small group format twice weekly for 60 minutes over 12 weeks.

Timeline

Start date
2006-08-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2011-03-09
Last updated
2011-03-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01311427. Inclusion in this directory is not an endorsement.